We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

4basebio plc (4BB) ORD EUR1

Sell:700.00p Buy:770.00p 0 Change: 5.00p (0.68%)
Market closed |  Prices as at close on 21 October 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:700.00p
Buy:770.00p
Change: 5.00p (0.68%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 October 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:700.00p
Buy:770.00p
Change: 5.00p (0.68%)
Market closed |  Prices as at close on 21 October 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

4basebio PLC is a United Kingdom-based specialist life sciences company. The Company is engaged in developing next generation gene therapy technologies and solutions. The Company is focused on supplying therapeutic deoxyribonucleic (DNA) for gene therapies and DNA vaccines and also for providing solutions for delivery of the DNA based products to patients. The Company focuses to manufacture and supply synthetic DNA for research, therapeutic and pharmacological use. Its TruePrime DNA amplification technology is a primer free DNA amplification method using enzymes. Its Hermes is a non-viral delivery platform that can be used to deliver various payloads, ranging from DNA to small interfering ribonucleic acid (siRNA), as well as protein cargoes. It also offers a messenger ribonucleic acid (mRNA) production service from the DNA template it makes. It offers a range of services including production of synthetic DNA and RNA payloads, design and assembly of payloads in nanoparticles.

Contact details

Address:
25 Norman Way, Over
CAMBRIDGE
CB24 5QE
United Kingdom
Telephone:
+44 (01223) 967943
Website:
https://www.4basebio.com/

Important dates

Future events
There are no future events available.
Past events
AGM 30 June 2021 30/06/21
Final results 03 June 2021 03/06/21

General stock information

EPIC:
4BB
ISIN:
GB00BMCLYF79
Market cap:
£90.53 million
Shares in issue:
12.32 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.